课题基金 / 基金详情

项目摘要

项目成果

Alban P Gaultier的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):多发性硬化症(MS)是一种慢性自身免疫性疾病,其特征是CNS髓鞘降解。该病的病因尚不清楚,然而,少突胶质细胞凋亡可能是一个起始事件。凋亡细胞体和降解髓鞘的去除的调节缺陷可以刺激免疫应答,因此有助于疾病的发展和/或进展。低密度脂蛋白受体相关蛋白-1(LRP 1)是一种细胞受体,在细胞内吞和细胞信号传导中发挥作用。我们已经证明LRP 1是体外髓鞘的关键内吞受体。此外,LRP 1水平在经历MS、EAE模型的小鼠的脑和脊髓中增加。我们推测LRP 1可能通过介导髓鞘降解和凋亡细胞清除直接参与MS的调控。我们将通过体内和体外实验的结合来检验这一假设。由于LRP 1完全缺乏是致命的,因此将使用骨髓细胞中具有条件性LRP 1缺乏的小鼠来确定LRP 1在EAE模型中的作用。使用该模型,我们在初步实验中证明LRP 1缺乏导致EAE症状显著增加,表明骨髓细胞中的LRP 1功能抑制疾病。LRP 1缺陷的巨噬细胞和小胶质细胞的效应功能将被表征。最后,我们建议确定LRP 1配体的髓鞘制剂,使用蛋白质组学发现的方法。这项研究资助提案应该为理解LRP 1在MS中的功能以及MS患者新型治疗方法的潜在开发提供基础。 公共卫生相关性:多发性硬化症(MS)是一种慢性疾病,其特征是免疫系统攻击髓鞘,这是正常脑功能所必需的。这项建议的重点是细胞蛋白质,LRP 1,我们表明这是重要的降解髓鞘的清除,并可能抑制疾病。我们的目标是确定LRP 1在MS中发挥作用的机制,并有可能发现开发MS患者新治疗方法的方法。
英文摘要
DESCRIPTION (provided by applicant): Multiple sclerosis (MS) is a chronic autoimmune disease characterized by degradation of the CNS myelin. Etiology of the disease is still unknown; however, oligodendrocyte apoptosis may represent an initiating event. Defects in the regulation of the removal of apoptotic cell bodies and degraded myelin can fuel the immune response and, thus, contribute to disease development and/or progression. Low density lipoprotein receptor-related protein-1 (LRP1) is a cellular receptor which functions in endocytosis and cell signaling. We have demonstrated that LRP1 is a key endocytic receptor for myelin in vitro. In addition, LRP1 levels are increased in the brains and spinal cords of mice subjected to a model of MS, EAE. We hypothesize that LRP1 could be directly involved in the regulation of MS by mediating degraded myelin and apoptotic cell removal. We will test this hypothesis by a combination of in vivo and in vitro experiments. As complete LRP1 deficiency is lethal, the role of LRP1 in the EAE model will be determined using mice with the conditional LRP1 deficiency in myeloid cells. Using this model, we demonstrate in preliminary experiments that LRP1 deficiency leads to a significant increase in EAE symptoms, suggesting that LRP1 function in myeloid cells inhibits disease. Effector functions of LRP1-deficient macrophages and microglia will be characterized. Finally, we propose to identify LRP1 ligands in myelin preparations, using a proteomics discovery approach. This research grant proposal should provide the basis for understanding the function of LRP1 in MS and for the potential development of novel therapeutics for MS patients. PUBLIC HEALTH RELEVANCE: Multiple sclerosis (MS) is a chronic disease characterized by the immune system attack on myelin sheath, which is necessary for proper brain function. This proposal is focused on a cellular protein, LRP1, which we show is important in the clearance of degraded myelin and may inhibit disease. We aim to identify the mechanisms by which LRP1 functions in MS, with potential of discovering ways leading towards development of novel treatments for MS patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the impact of Clusterin on the oligodendrocyte lineage in AD
  • 批准号:
    10539074
  • 项目类别:
  • 资助金额:
    $162.15万
  • 财政年份:
    2022
  • 负责人:
    Alban P Gaultier
  • 依托单位:
Discovering new therapies to promote myelin repair
  • 批准号:
    10314338
  • 项目类别:
  • 资助金额:
    $44.0万
  • 财政年份:
    2021
  • 负责人:
    Alban P Gaultier
  • 依托单位:
The role of oligodendrocyte progenitor cells in neuroinflammation
  • 批准号:
    10355928
  • 项目类别:
  • 资助金额:
    $46.27万
  • 财政年份:
    2021
  • 负责人:
    Alban P Gaultier
  • 依托单位:
NOVO-118 as a therapeutic to promote remyelination in in vivo models of MS
  • 批准号:
    10011900
  • 项目类别:
  • 资助金额:
    $35.41万
  • 财政年份:
    2019
  • 负责人:
    Alban P Gaultier
  • 依托单位:
海外基金